Enzymatic Metabolism of Flavonoids by Gut Microbiota and Its Impact on Gastrointestinal Cancer
Gastrointestinal (GI) cancer is a prevalent global health disease with a massive burden on health care providers. Internal and external factors such as obesity, smoking, diet (red meat), low socioeconomic status and infection with <i>Helicobacter pylori</i> are the critical risk factors...
Main Authors: | Raghad Khalid AL-Ishaq, Alena Liskova, Peter Kubatka, Dietrich Büsselberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/16/3934 |
Similar Items
-
Flavonoids’ Dual Benefits in Gastrointestinal Cancer and Diabetes: A Potential Treatment on the Horizon?
by: Raghad Khalid AL-Ishaq, et al.
Published: (2022-12-01) -
Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer
by: Raghad Khalid AL-Ishaq, et al.
Published: (2022-04-01) -
Sweeteners and the Gut Microbiome: Effects on Gastrointestinal Cancers
by: Raghad Khalid AL-Ishaq, et al.
Published: (2023-08-01) -
Pathogenic role of the gut microbiota in gastrointestinal diseases
by: Hiroko Nagao-Kitamoto, et al.
Published: (2016-04-01) -
Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs
by: Manaal Siddiqui, et al.
Published: (2021-03-01)